What is the recommended blood glucose target range for ICU patients?

Recommended Blood Glucose Target Range for ICU Patients

For critically ill adult ICU patients, target a blood glucose range of 7.8–11.1 mmol/L (140–200 mg/dL), initiating insulin therapy when glucose persistently exceeds 10 mmol/L (180 mg/dL). 1

Initiation Threshold

• Start insulin therapy when blood glucose reaches ≥10 mmol/L (180 mg/dL) on two consecutive measurements in both adults and children 1
• This trigger threshold is intentionally lower than the upper target limit to prevent prolonged hyperglycemia above the treatment range 1
• The Society of Critical Care Medicine 2024 guidelines establish this as a good practice statement for all critically ill patients 1

Target Range: Why Higher is Better

The evidence strongly supports avoiding intensive (tight) glucose control in favor of conventional (moderate) control:

• Target range of 7.8–11.1 mmol/L (140–200 mg/dL) is recommended over intensive control of 4.4–7.7 mmol/L (80–139 mg/dL) 1
• The 2024 SCCM guidelines provide a conditional recommendation (moderate certainty) against intensive glucose targets due to increased hypoglycemia risk without mortality benefit 1
• For pediatric patients, this is a strong recommendation against intensive control 1

Critical Rationale

Hypoglycemia poses greater immediate harm than moderate hyperglycemia:

• Severe hypoglycemia (<2.2 mmol/L) occurred in 13.2% of patients with tight control versus 6.2% with conventional control in a large randomized trial, with no mortality benefit from tighter control 2
• Meta-analyses demonstrate that an upper limit of 10 mmol/L (180 mg/dL) is associated with better outcomes than lower targets, particularly in diabetic patients 3
• Neurotoxic effects and wound-healing disturbances result from hypoglycemia, making avoidance the primary therapeutic strategy 3

Special Considerations for Diabetic Patients

• Patients with pre-existing diabetes do not benefit from intensive glucose reduction to the same extent as non-diabetic patients but face similar hypoglycemia risks 3
• The target range of 7.8–10 mmol/L (140–180 mg/dL) represents the best compromise for optimizing outcomes while avoiding hypoglycemia in diabetic ICU patients 3
• Emerging evidence suggests potential benefit from personalized targets matching chronic pre-hospital glycemic control (based on HbA1c), though this requires further study 1

Implementation Strategy

Use continuous IV insulin infusion with frequent monitoring:

• Continuous IV insulin is preferred over subcutaneous insulin for acute hyperglycemia management in critically ill adults (conditional recommendation, very low certainty) 1
• Monitor glucose at intervals ≤1 hour during periods of glycemic instability (conditional recommendation, low certainty) 1
• Employ protocols with explicit clinical decision support tools to improve glucose control and reduce hypoglycemia risk (conditional recommendation, moderate certainty) 1

Common Pitfalls to Avoid

• Do not pursue intensive glucose control (80–139 mg/dL) as this increases hypoglycemia without improving mortality 1, 2
• Do not delay treatment of hypoglycemia when it occurs—immediate correction is essential 1
• Do not use point-of-care glucose meters without awareness of their limitations in critically ill patients, as accuracy can be compromised 4
• Avoid therapeutic ranges below 4.4 mmol/L (79 mg/dL), which cannot be justified even in non-diabetic patients 3